In a world increasingly focused on eco-conscious living, the cosmetic industry is actively adopting nanotechnology to transform plant and animal by-products into high-value beauty products. This comprehensive review explores the innovative and sustainable approaches for extracting and utilizing bioactive compounds from these by-products. The application of nanocarrier systems is highlighted for their role in enhancing the delivery efficacy and safety of these ingredients in skincare and beauty products. Consumer demand and environmental concerns drive the shift towards natural and sustainable cosmetic products. Traditional cosmetic production often involves significant ecological impacts, prompting the industry to seek greener alternatives. This review addresses the critical need for sustainable beauty solutions that align with global sustainability goals, particularly those outlined in the 2030 Agenda for Sustainable Development. The review provides valuable insights into current trends and future directions in sustainable cosmetics by focusing on nanotechnology and by-products. The review uniquely integrates nanotechnology with sustainability practices in the cosmetic industry. It details the benefits of using nanocarriers to improve the stability, bioavailability, and efficacy of bioactive compounds derived from natural waste. This intersection of high-tech methodologies and sustainability offers a novel perspective on cosmetic innovation. Future research should focus on overcoming the technical, regulatory, and economic challenges of scaling up nanotechnology applications. Investigations should include the development of transparent supply chains, standardization methods for characterizing nanoparticles, and comprehensive lifecycle assessments to ensure environmental safety. Additionally, fostering collaboration between scientific research, industry practices, and consumer education is vital for advancing sustainable practices. This review contributes to the broader discourse on sustainable beauty by presenting a clear pathway for integrating these innovative approaches. It ensures that future cosmetic products meet consumer expectations for efficacy and safety and promote environmental stewardship and a circular economy, ultimately benefiting both the skin and the planet.

Gliomas are the most common type of brain cancer, and among them, glioblastoma multiforme (GBM) is the most prevalent (about 60% of cases) and the most aggressive type of primary brain tumor. The treatment of GBM is a major challenge due to the pathophysiological characteristics of the disease, such as the presence of the blood-brain barrier (BBB), which prevents and regulates the passage of substances from the bloodstream to the brain parenchyma, making many of the chemotherapeutics currently available not able to reach the brain in therapeutic concentrations, accumulating in non-target organs, and causing considerable adverse effects for the patient. In this scenario, nanocarriers emerge as tools capable of improving the brain bioavailability of chemotherapeutics, in addition to improving their biodistribution and enhancing their uptake in GBM cells. This is possible due to its nanometric size and surface modification strategies, which can actively target nanocarriers to elements overexpressed by GBM cells (such as transmembrane receptors) related to aggressive development, drug resistance, and poor prognosis. In this review, an overview of the most frequently overexpressed receptors in GBM cells and possible approaches to chemotherapeutic delivery and active targeting using nanocarriers will be presented.

Glioblastoma multiforme is the most common and aggressive malignant tumor that affects the central nervous system, with high mortality and low survival. Glioblastoma multiforme treatment includes resection tumor surgery, followed by radiotherapy and chemotherapy adjuvants. However, the drugs used in chemotherapy present some limitations, such as the difficulty of crossing the bloodbrain barrier and resisting the cellular mechanisms of drug efflux. The use of polymeric nanoparticles has proven to be an effective alternative to circumvent such limitations, as it allows the exploration of a range of polymeric structures that can be modified in order to control the biodistribution and cytotoxic effect of the drug delivery systems. Nanoparticles are nanometric in size and allow the incorporation of targeting ligands on their surface, favoring the transposition of the blood-brain barrier and the delivery of the drug to specific sites, increasing the selectivity and safety of chemotherapy. The present review has described the characteristics of chitosan, poly(vinyl alcohol), poly(lactic-coglycolic acid), poly(ethylene glycol), poly(β-amino ester), and poly(ε-caprolactone), which are some of the most commonly used polymers in the manufacture of nanoparticles for the treatment of glioblastoma multiforme. In addition, some of the main targeting ligands used in these nanosystems are presented, such as transferrin, chlorotoxin, albumin, epidermal growth factor, and epidermal growth factor receptor blockers, explored for the active targeting of antiglioblastoma agents.